Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models | |
Yang, Weimin1; Qiang, Dongjin1; Zhang, Min1; Ma, Limei1; Zhang, Yonghui1; Qing, Chen1; Xu, Yunlong2; Zhen, Chunlan1; Liu, Jikai2; Chen, Yan-Hua3 | |
通讯作者 | Yang, WM (reprint author), Kunming Med Coll, Yunnan Key Lab Pharmacol Nat Prod, Kunming 650031, Peoples R China |
2011-06-01 | |
发表期刊 | INTERNATIONAL IMMUNOPHARMACOLOGY |
ISSN | 1567-5769 |
卷号 | 11期号:6页码:683-692 |
摘要 | Isoforskolin was isolated from Coleus forskohlii native to Yunnan in China. We hypothesize that isuforskolin pretreatment attenuates acute lung injury induced by lipopolysaccharide (endotoxin). Three acute lung injury models were used: situ perfused rat lung, rat and mouse models of endotoxic shock. Additionally, lipopolysaccharide stimulated proinflammatory cytokine production was evaluated in human mononuclear leukocyte. In situ perfused rat lungs, pre-perfusion with isoforskolin (100, and 200 mu M) and dexarrethasone (65 mu M, positive control) inhibited lipopolysaccharide (10 mg/L) induced increases in lung neutrophil adhesion rate, myeloperoxidase activity, lung weight Wet/Dry ratio, permeability-surface area product value, and tumor necrosis factor (TNF)-alpha levels. In rats, pretreatments with isoforskolin (5, 10, and 20 mg/kg, i.p.) and dexamethasone (5 mg/kg, i.p.) markedly reduced lipopolysaccharide (6 mg/kg i.v.) induced increases of karyocyte, neutrophil counts and protein content in bronchoalveolar lavage fluid, and plasma myeloperoxidase activity. Lung histopathology showed that morphologic changes induced by lipopolysaccharide were less pronounced in the isoforskolin and dexamethasone pretreated rats. In mice, 5 mg/kg isoforskolin and dexamethasone caused 100% and 80% survival, respectively, after administration of lipopolysaccharide (62.5 mg/kg, iv., 40% survival if untreated). In human mononuclear leukocyte, isoforskolin (50, 100, and 200 mu M) and dexamethasone (10 mu M) pre-incubation lowered lipopolysaccharide (2 mu g/mL) induced secretion of the cytokine TNF-alpha, and interleukins (IL)-1 beta, IL-6, and IL-8. In conclusion, pretreatment with isoforskolin attenuates lipopolysaccharide-induced acute lung injury in several models, and it is involved in down-regulation of inflammatory responses and proinflammatory cytokines TNF-alpha, IL-1 beta, IL-6, and IL-8. (C) 2011 Elsevier B.V. All rights reserved. |
关键词 | Acute Lung Injury Isoforskolin Lipopolysaccharide Inflammation Cytokine |
学科领域 | Immunology ; Pharmacology & Pharmacy |
DOI | 10.1016/j.intimp.2011.01.011 |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000291505900007 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.kib.ac.cn/handle/151853/5353 |
专题 | 植物化学与西部植物资源持续利用国家重点实验室 |
作者单位 | 1.Kunming Med Coll, Yunnan Key Lab Pharmacol Nat Prod, Kunming 650031, Peoples R China 2.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming 650204, Peoples R China 3.E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA |
推荐引用方式 GB/T 7714 | Yang, Weimin,Qiang, Dongjin,Zhang, Min,et al. Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models[J]. INTERNATIONAL IMMUNOPHARMACOLOGY,2011,11(6):683-692. |
APA | Yang, Weimin.,Qiang, Dongjin.,Zhang, Min.,Ma, Limei.,Zhang, Yonghui.,...&Chen, Yan-Hua.(2011).Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models.INTERNATIONAL IMMUNOPHARMACOLOGY,11(6),683-692. |
MLA | Yang, Weimin,et al."Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models".INTERNATIONAL IMMUNOPHARMACOLOGY 11.6(2011):683-692. |
条目包含的文件 | 下载所有文件 | |||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
201203200026.pdf(2189KB) | 开放获取 | -- | 浏览 下载 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论